HealthcareServices

Pediatric Clinical Trials Market Forecast 2026–2035: Data Trends and Industry Insights

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pediatric clinical trials market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Pediatric Clinical Trials Market between 2026 and 2030?_x000D_

The pediatric clinical trials market size has experienced significant expansion in recent years. This market is projected to grow from $18.38 billion in 2025 to $19.75 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. The historical expansion observed within this market was influenced by elements such as constrained pediatric-specific drug research, a reliance on data from adult trials, inherent ethical and regulatory obstacles, difficulties in patient recruitment, and the limited utilization of advanced analytics in trial design._x000D_

_x000D_

The pediatric clinical trials market is set to experience robust expansion over the next few years. It is anticipated to grow to $26.67 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.8%. This growth in the forecast period can be attributed to the rising demand for therapies tailored for children, the increased adoption of digital and AI-powered tools, growing regulatory incentives for pediatric studies, expanding collaborations between pharmaceutical companies and research institutions, and a heightened focus on patient-centric and personalized clinical trials. Major trends identified for this period include the increasing integration of precision medicine into pediatric clinical trials, the rising application of AI and digital technologies for trial design and data analysis, the growing incorporation of real-world evidence in pediatric research, increased investment in the development of pediatric drugs, and a heightened emphasis on personalized and age-specific therapeutic approaches._x000D_

_x000D_

#Access Your Free Sample Report for In-Depth Market Insights:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=10350&type=smp_x000D_

_x000D_

Which Drivers Are Expected To Impact The Pediatric Clinical Trials Market During The Forecast Period?_x000D_

An anticipated increase in pediatric cancer cases is set to drive growth in the pediatric clinical trials market in the future. Pediatric cancer is defined as malignancies that emerge in children and young people below the age of 14. These cancers are very rare, and their patterns of development and spread can differ from adult tumors. Pediatric clinical trials remain crucial for improving prognoses and therapeutic approaches. For example, the American Cancer Society, a voluntary health organization in the US, reported in January 2023 an estimation that approximately 9,910 children in the US under the age of 15 would be diagnosed with cancer, and around 1,040 children under the age of 15 were projected to succumb to cancer in 2023. Consequently, expanding healthcare spending is propelling the pediatric clinical trials market._x000D_

_x000D_

How Is The Pediatric Clinical Trials Market Divided Into Segments?_x000D_

The pediatric clinical trials market covered in this report is segmented –_x000D_

_x000D_

1) By Phase: Phase I, Phase II, Phase III, Phase IV_x000D_

2) By Study Design: Treatment Studies, Observational Studies_x000D_

3) By Therapeutic Areas: Infectious Diseases, Oncology, Autoimmune Or Inflammatory Diseases, Respiratory Disorders, Mental Health Disorders, Other Therapeutic Areas_x000D_

_x000D_

Subsegments:_x000D_

1) By Phase I: First-in-Pediatrics Trials, Dose Escalation Studies, Safety And Tolerability Assessments_x000D_

2) By Phase II: Efficacy Studies, Dose Optimization Trials, Pharmacokinetic Studies_x000D_

3) By Phase III: Large-Scale Efficacy Trials, Comparative Studies, Long-Term Safety Studies_x000D_

4) By Phase IV: Post-Marketing Surveillance, Long-Term Safety Monitoring, Effectiveness Studies In Real-World Settings_x000D_

_x000D_

Which Trends Are Expected To Influence The Pediatric Clinical Trials Market In The Upcoming Years?_x000D_

Leading organizations engaged in pediatric clinical investigations are concentrating on collaboration and alliances to offer dependable services to consumers. A strategic partnership denotes a formalized relationship between two or more commercial entities, typically established through one or more business agreements or contracts. For example, in September 2023, Strados Labs, a US-based supplier of smart biosensors for tracking respiration, joined forces with Ann & Robert H. Lurie Children’s Hospital, a US-based pediatric acute care children’s hospital, to conduct a clinical study for the RESP Biosensor. The RESP Biosensor is a wearable instrument that utilizes acoustic sensors to monitor lung sounds for asthma signs like coughing and wheezing. The objective of this clinical trial is to evaluate the efficacy of the RESP Biosensor in precisely detecting and observing asthma exacerbations in children._x000D_

_x000D_

Which Leading Companies Dominate The Pediatric Clinical Trials Market Share?_x000D_

Major companies operating in the pediatric clinical trials market are Medpac Inc., Pharmaceutical Product Development Inc., ICON plc, Syneos Health Inc., QPS Holdings LLC, Pfizer Inc., IQVIA Inc., Premier Research, Labcorp – Laboratory Corporation of America Holdings, The Emmes Company LLC, Synteract Inc., Charles River Laboratories International Inc., Covance Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, BioNTech SE, Moderna Inc., Parexel International Corporation, PRA Health Sciences, Wuxi AppTec, Merck & Co. Inc., AstraZeneca plc, Sanofi S.A., Johnson & Johnson, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Oracle Health sciences_x000D_

_x000D_

#Access The Complete Report For Deeper Market Insights:#_x000D_

https://www.thebusinessresearchcompany.com/report/pediatric-clinical-trials-global-market-report_x000D_

_x000D_

How Does The Pediatric Clinical Trials Market Perform Across Major Global Regions?_x000D_

North America was the largest region in the pediatric clinical trials market in 2025. The regions covered in the pediatric clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request Your Customized Pediatric Clinical Trials Market Research Report for Competitive Advantage:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=10350&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Pediatric Clinical Trials Market 2026, By The Business Research Company#_x000D_

_x000D_

Clinical Trial Supplies Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/clinical-trial-supplies-global-market-report_x000D_

_x000D_

Pediatric Supplements Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/pediatric-supplements-global-market-report_x000D_

_x000D_